Drug Trial Radar · NCT04325035
The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock
Last checked: Nov 19, 2026Latest source record: Feb 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
90
Actual
Start
Sep 28, 2020
Primary completion
Sep 26, 2024
Study completion Oct 30, 2024
Sponsor
- Lead sponsor
- Windtree TherapeuticsIndustry
- Sponsor type
- Industry
- Collaborators
- Momentum Research, Inc.
- First posted
- Mar 27, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a pilot, multinational, randomized, double-blind, placebo-controlled, 2-part safety and efficacy study. Subjects will consist of patients hospitalized for acute decompensated heart failure with persistent hypotension.
Conditions
- Cardiogenic Shock
Interventions
IstaroximeDrug
Reconstituted istaroxime and lactose lyophilized powder delivered via IV infusion
PlaceboDrug
Reconstituted placebo (lactose lyophilized powder) delivered via IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in systolic blood pressure (SBP) area under the curve (AUC) 0-6Time frame: 0 to 6 hours after initiation of infusion
Locations
13 sites in 4 countries. Site status is shown where the registry gives one.
Tufts Medical Center
Boston, Massachusetts
Santorio de la Trinidad Palermo
Buenos Aires, Argentina
Hospital Italiano de Bueno Aires
Capital Federal, Buenos Aires, Argentina
Santorio Guemes
Capital Federal, Buenos Aires, Argentina
Hospital Privado de Rosario
Rosario, Sante Fe, Argentina
Instituto Cardiovascular de Rosario
Rosario, Sante Fe, Argentina
Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo
Alessandria, Italy
UOC Cardiologia, ASST degli Spedali Civili di Brescia Pizzale Spedali Civili 1
Brescia, Italy
IRCCS San Raffaele Scientific Institute
Milan, Italy
Uniwersytecki Szpital Kliniczny w Białymstoku
Bialystok, Poland
Uniwersytecki Szpital Kliniczny w Opolu
Opole, Poland
4 Wojskowy Szpital Kliniczny
Wroclaw, Poland
Uniwersytecki Szpital Kliniczny, Centrum Chorub Serca
Wroclaw, Lower Silesian Voivodeship, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.